
NHS Faces Scrutiny Over Palantir Software Rollout Amid Staff Concerns
The NHS implementation of Palantir data software has drawn criticism from lawmakers and internal staff warnings about public criticism of the rollout.

The NHS implementation of Palantir data software has drawn criticism from lawmakers and internal staff warnings about public criticism of the rollout.

Telehealth providers are playing an increasingly important role in determining how employers cover expensive obesity drugs through insurance plans.

The parasitic New World screwworm has reemerged in the United States after being eradicated decades ago, with officials authorizing emergency pet treatments.

Scientists report progress on new treatments for hair loss affecting women and ovarian cancer therapies that extend patient survival.
CBS News investigation finds allegations of abuse and lack of federal oversight in multibillion-dollar youth residential treatment industry.
Biotech company Replimune will resubmit its experimental melanoma treatment for FDA approval following two prior rejections over study design concerns.

Utz Quality Foods has issued a nationwide recall of certain Zapp's and Dirty brand potato chips due to potential salmonella contamination in an ingredient.

A safety investigation into WellBN clinic in Brighton found dozens of children were potentially harmed by gender medication given without proper checks.

Federal officials are asking insurers to consider providing loans to consumers struggling with high deductibles under Affordable Care Act plans.

New medical research explores connections between sleep patterns and dementia risk, while other studies examine gut bacteria's role in sepsis susceptibility.
Danish pharmaceutical company Novo Nordisk reported strong sales and prescription numbers for its weight-loss medication Wegovy, leading to updated financial guidance.

The family of a 17-year-old Texas cheerleader filed a wrongful death lawsuit, claiming she died from an enlarged heart after consuming energy drinks.

A Health and Human Services inspector general report found Medicare Advantage plans denied prior authorization requests at unusually high rates.

Regeneron faces trial setback, Bristol Myers partners with China, and first GLP-1 gene therapy trial approved.

Research suggests GLP-1 medications may reduce substance use disorders while changing food preferences drives interest in flavor companies.
Page 13 of 42 (620 stories)